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INTRODUCTION
Human papillomavirus (HPV) has been detected in vari-
ous benign or malignant epidermal tumors (1-5). Seborrhe-
ic keratoses (SK), which are benign epidermal tumors, are
similar and often confused with warts in their clinical and/
or histological appearance. These similarities have led inves-
tigators to study the role of HPV in the pathogenesis of
seborrheic keratoses (6-10).
Zhao et al. (6) detected, by electron microscopy, HPV-
like particles in 4 of 89 nongenital SK. In cases of seborrheic
keratoses of cases of the genital area, HPV has been report-
edly found in 42% (n=57) using polymerase chain reaction
(PCR) from tissue extracts (7). However, the same group
reported lack of HPV-DNA in nongenital SK (8), demon-
strated by PCR from tissue extracts (n=27). Soler et al. (9)
showed HPV type 5 DNA by in situ hybridization in a
nongenital SK obtained from a renal transplant recipient.
Recently, Tsambaos et al. (10) detected HPV-DNA in 20%
(34/173) of nongenital SK specimens using in situ hybridi-
zation.
We believe that it is necessary to clarify the discrepancies
of HPV-DNA detection in nongenital SK using accurate and
sensitive methods. To demonstrate the presence of HPV in
nongenital SK, we analyzed 40 biopsy specimens taken from
patients with nongenital SK using in situ PCR and PCR from
tissue extracts.
MATERIALS AND METHODS
To investigate the possibility that HPV might be a causa-
tive factor for SK, 40 nongenital SK tissue sections were exam-
ined for the presence of HPV 6/11, 31 or 33 DNA by PCR
and in situ PCR.
Tissue samples
A series of 40 formalin-fixed and paraffin-embedded biop-
sy specimens were collected as tissue samples. Paraffin-embed-
ded tissue samples were retrieved from archival diagnostic
specimens. The specimens were taken from 40 patients, 22
men and 18 women, who had visited the Dermatology De-
partment of Ajou University Hospital from October 1997
to October 1999. Biopsy sites included the face (n=15), trunk
(n=8), scalp (n=7), leg (n=3), neck (n=2), arm (n=2), hand
(n=1), back (n=1), and buttock (n=1). All specimens used
in this study showed the typical histological features of SK.
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Absence of Human Papillomavirus DNA in Nongenital Seborrheic
Keratosis
Seborrheic keratosis (SK) is a benign epidermal tumor of unknown etiology.
Because of its wart-like morphology, human papillomavirus (HPV) has been sug-
gested as a possible causative agent. Viral involvement, however, has not been
confirmed yet despite extensive research. The aim of this study was to evaluate
the presence of HPV 6/11, 31, 33 DNA in nongenital SK. We analyzed 40 biopsy
specimens taken from patients with nongenital SK using in situ polymerase chain
reaction (PCR) and PCR with tissue extracts. The SK specimens (n=40), analyzed
by in situ PCR, were negative for all HPV probes tested (types 6/11, 31, 33).
Control slides (condyloma acuminatum, n=3) were positive for type 6/11, 31, and
33 HPV probes tested. Melasma samples (n=4), the negative controls, were
consistently negative. No HPV DNA band was detected by PCR with the tissue
extracts from paraffin-embedded SK samples, while condyloma acuminatum, the
positive controls, showed DNA bands of the correct molecular weights. Our
results show that HPV type 6/11, 31, and 33 cannot be recognized as  causative
agents for nongenital SK, which is in contrast to the previous studies. Further
studies are required to reveal the presence of other types (more than 90) of HPV
DNA.
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Samples included 8 hyperkeratotic types and 32 acanthotic
types of SK. The diagnosis was confirmed again after reex-
amination of clinical photos and histological slides by two
dermatologists (WHK and ESL). We used 3 specimens of
condyloma acuminatum as the positive controls and 5 spec-
imens of melasma as the negative controls.
In situ PCR
In our study, in situ PCR was modified from Nuovo’ s
method (11). Four  m tissue sections were prepared and
dewaxed with xylene for 30 min and 100% ethanol for 5
min. The samples were gradually rehydrated using a graded
series of alcohols and digested with 20  g/mL proteinase K
(Behringer Manheim Co., Indianapolis, IN, U.S.A.), in PBS
for 10 min at 37℃. The samples were washed extensively in
phosphate-buffered saline (PBS) to inactivate the enzyme.
The slides were dehydrated in a graded series of alcohols
and their PCR amplification was performed using the in
situ thermal cyclers (M J Research, Waltham, MA, U.S.A.).
PCR reaction was performed using type-specific primers.
We synthesized the primers for HPV 6/11, 31, 33 as fol-
lows: HPV 6/11 (F) 5′ -AAGGGCGTAACCGAAATCGGT-
3′ , (R) 5′ -TGTCACAAACCGCTGTGTGA-3′ ; HPV 31
(F) 5′ -TGTCAAAGACCGTTGTGTCC-3′ , (R) 5′ -GAG
CTGTCGGGTAATTGCTC-3′ ; HPV 33 (F) 5′ -AAGG-
GCGTAACCGAAATCGGT-3′ , (R) 5′ -GTCTCCAAT-
GCTTGGCACA-3′ . Twenty-five  L PCR reaction mix-
tures contained Taq polymerase 0.8  L, 10×PCR buffer
2.5  L, 2.5 mM dNTPs 4  L, 1 mM digoxigenin-11-dUTP
1  L (Boehringer Mannheim Biochemicals, Indianapolis,
IN), 20 pmol/ L HPVpF 1  L, and 20 pmol/ L HPVpR 1
L. The slides were warmed to 82℃ for 7 min in order to
perform hot start PCR and then at 55℃, 25  L PCR reac-
tion mixture was placed directly on the tissue section and
covered with slide seal (TaKaRa Biomedicals, Japan) and
cycled as follows: 94℃for 3 min (1 cycle), followed by 55℃
for 2 min and 94℃ for 1 min (15 cycles). Slide seals were
removed and the tissue was washed in PBS for 5 min.
The samples were then incubated for 30 min with anti-
digoxigenin-alkaline phosphatase-conjugated Fab antibody
fragments (1:2,000 dilution; Boehringer Mannheim Bio-
chemicals, Indianapolis, IN) prepared in blocking buffer.
The slides were washed 3 times in tris buffer solution (pH
7.6). Freshly prepared BCIP/NBT (5′ -bromo-4-chloro-3-
indolyl-phosphate/nitroblue tetrazolium; Sigma Chemical
Co., St. Louis, MO, U.S.A.) was used as the chromogenic
substrate. Slides were covered with the substrate and moni-
tored for color development. The sections were then coun-
terstained with Mayer hematoxylin.
PCR analysis of tissue extracts
DNA amplification by PCR was carried out as previously
described (12) on the tissue samples. Briefly, 8  m thick
sections were deparaffinized in 1.5 mL microfuge tubes with
500  L xylene, followed by dehydration with 100% ethanol.
The samples were dried in a vacuum centrifuge, which were
digested overnight at 55℃with proteinase K (Sigma Chem-
ical Co., St. Louis, MO). Then, it was boiled in 95℃ heat
block to stop the reaction. Amplification of HPV DNA was
performed using the supernatant. We used PCR core kit
(Boehringer Mannheim Biochemicals, Indianapolis, IN,
U.S.A.) and GeneAmp PCR System 9600 (Perkin Elmer
Cetus, Norwalk, CT, U.S.A.). The PCR was implemented
using 30 cycles with the primers; 30 sec at 94℃, 2 min at
55℃, and 2 min at 72℃. PCR products were electrophoresed
on 1.5% agarose gel, stained with ethidium bromide, and
photographed under UV light. Positive and negative con-
trol reactions were included with all amplifications.
RESULTS
In situ PCR
The 40 tissue samples, analyzed by in situ PCR, were neg-
ative for all HPV probes tested (6/11, 31, 33) (Fig. 1A).
Control slides (condyloma acuminatum, n=3) were consis-
tently positive for type 6/11, 31, and 33 HPV probes tested
(Fig. 1B, C). Dark brown colored positive staining was ob-
served on the nuclei of keratinocytes in the upper stratum
malpighii and stratum corneum. Melasma samples (n=4),
the negative controls, were consistently negative.
PCR analysis of tissue extracts
No HPV DNA band was detected by PCR with the tis-
sue extracts from paraffin-embedded SK samples (n=40).
However, condyloma acuminatum (n=3), which served as
the positive controls, showed DNA bands of the correct
molecular weights (Fig. 2).
DISCUSSION
The present study, in situ PCR or PCR with SK tissue
extracts, could not demonstrate HPV genomes type 6/11,
31, or 33 in the nongenital SK tissue samples (n=40). This
result is contrary to the result by Tsambaos et al. (10), which
reported the presence of HPV genomes (6/11, 8.7%; 31/33/
35, 8%; other types, 2.9%; n=173). At present, we cannot
explain the discrepancy between the two studies.
We used very sensitive and specific methods to detect the
tissue HPV (type 6/11, 31, and 33). We believe that our
negative results are not technical errors for the following
reasons: 1) in situ PCR method used in this study is more
sensitive than in situ hybridization due to the advantages ofHuman Papillomavirus DNA in Nongenital Seborrheic Keratosis 621
both PCR and in situ hybridization and enabled us to visu-
alize the cellular localization of HPV DNA; 2) to confirm
the negative results of in situ PCR for the HPV DNA, we
performed PCR using SK tissue extracts, which revealed no
HPV DNA (type 6/11, 31, and 33); 3) the positive controls
(condyloma acuminatum, n=3) run simultaneously showed
definite dark brown colored staining of the nuclei (Fig. 1B,
C), while the negative controls (melasma, n=4) did not show
the staining pattern.
One possible explanation might be that the venereal HPV
transmission would increase the risk of exposure of both sites
(genital and periungual) to HPV infection (13). Therefore,
despite the same disease entity, the affected site could be the
source of such differences in virus detection. For example,
Mitsuishi et al. (14) detected HPV DNA in Bowen’ s dis-
ease of the hands, while Lu et al. (4 hand from total 91) (13)
failed to demonstrate the presence of HPV DNA in Bowen’
s disease of the skin.  Similar results have also been reported
with squamous cell carcinoma (15, 16). In our study, only
one specimen was taken from the finger, which might part-
ly explain our negative results.
In conclusion, we believe that HPV type 6/11, 31, and 33
can not be recognized as causative agents for nongenital SK
in contrast to the previous study (10). The present study has
checked 4 types (6/11, 31, and 33) of HPV DNA among more
than 90 types. Further studies are required to reveal the pres-
ence of other types of HPV DNA, which would help to clarify
the role of HPV in the pathogenesis of nongenital SK.
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Fig. 1. (A) No HPV 6/11 DNA was detected with in situ PCR in
nongenital seborrheic keratosis (digoxigenin alkaline phos-
phatase; hematoxylin counterstain; ×200). (B) Demonstration
of HPV 6/11 DNA in nuclei of keratinocytes in the upper epider-
mal layers of a condyloma acuminatum (digoxigenin alkaline
phosphatase; hematoxylin counterstain; ×100). (C) A magnifi-
cation clearly shows well-stained (brown colored) keratinocyte
nuclei in the upper epidermal layers of a condyloma acumina-
tum (digoxigenin alkaline phosphatase; hematoxylin counter-
stain; ×400).622 E.-S. Lee, M.R. Whang, W.H. Kang
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Fig. 2. Ethidium-stained 1.5% agarose gel demonstrating HPV
6/11 DNA amplimers. Lane A indicates molecular weight markers;
lane B, condyloma acuminatum, Lane C through G, SKs. Lane B
is positive for HPV 6/11 DNA. Lane C through G are negative. 